2020 US Pharma

U.S. Food Companies Rankings using Artificial Intelligence

Top rated90 of 362
Best rating669\u2009%
Worst rating-1,971\u2009%
New companies47
Negative Economic Capital Ratio91 of 362

BIO-PATH HOLDINGS INC climbed 300 positions from 331 to 31 due it’s excellent Assets, Current. Sesen Bio Inc. lost 296 positions from 27 to 323 due it’s bad Assets, Current. XBiotech Inc. entered the 2020 ranking at rank 1, making it the best newcomer.

Revenues385\u2009B
Assets1.00\u2009K
Expenses345\u2009B
Stockholders Equity516\u2009B
Unprofitable companies317 of 362

1. XBiotech Inc.

807.66%

4. Catalent Inc.

395.83%

19. AbbVie Inc.

211.31%

20. Xencor Inc

205.00%

21. Merck & Co. Inc.

200.55%

22. ABBOTT LABORATORIES

192.79%

24. MARIZYME INC

186.14%

28. Pfenex Inc.

171.99%

29. PROCYON CORP

169.02%

32. Lifevantage Corp

144.40%

41. NextCure Inc.

110.83%

46. AMARIN CORP PLCUK

99.84%

47. PFIZER INC

99.57%

49. JOHNSON & JOHNSON

98.01%

50. ELI LILLY & Co

92.66%

54. Zoetis Inc.

87.06%

57. PERRIGO Co plc

84.40%

59. LANDEC CORP CA

77.24%

60. MEDICINOVA INC

71.46%

64. HARROW HEALTH INC.

65.35%

65. Allergan plc

64.55%

66. XOMA Corp

54.71%

67. Mylan II B.V.

54.69%

74. OPKO HEALTH INC.

32.87%

78. ANAPTYSBIO INC

22.46%

81. Aravive Inc.

4.18%

84. Forty Seven Inc.

-3.07%

86. Kura Oncology Inc.

-11.13%

90. NEKTAR THERAPEUTICS

-18.23%

91. ARVINAS INC.

-18.78%

93. EXICURE INC.

-23.99%

94. MEI Pharma Inc.

-26.51%

96. SYNLOGIC INC.

-32.35%

98. VERU INC.

-35.30%

101. Merus N.V.

-41.54%

104. Monopar Therapeutics

-46.60%

106. DURECT CORP

-47.85%

107. Kadmon Holdings Inc.

-50.67%

108. Teligent Inc.

-51.18%

110. uniQure N.V.

-51.46%

113. AKORN INC

-57.25%

118. Atreca Inc.

-66.84%

121. GLYCOMIMETICS INC

-71.99%

122. LANNETT CO INC

-72.28%

123. Societal CDMO Inc.

-72.94%

128. VIVUS INC

-80.49%

129. Orgenesis Inc.

-83.83%

133. ChemoCentryx Inc.

-86.12%

135. CV Sciences Inc.

-92.81%

136. Advaxis Inc.

-93.99%

139. BIO-PATH HOLDINGS INC

-96.70%

142. Altimmune Inc.

-106.07%

143. ARDELYX INC.

-108.15%

147. Epizyme Inc.

-114.18%

152. ALBIREO PHARMA INC.

-124.71%

154. CONTRAFECT Corp

-127.72%

155. Zymeworks Inc.

-130.51%

156. GERON CORP

-130.71%

157. Arcus Biosciences Inc.

-134.79%

158. G1 Therapeutics Inc.

-137.56%

159. Evolus Inc.

-138.57%

167. BridgeBio Pharma Inc.

-150.05%

168. VBI Vaccines Inc BC

-151.84%

169. IVERIC bio Inc.

-153.72%

174. Equillium Inc.

-167.18%

176. Celsion CORP

-168.96%

177. CYTOKINETICS INC

-171.27%

180. Fortress Biotech Inc.

-175.10%

185. MACROGENICS INC

-183.90%

187. ImmunoGen Inc.

-185.32%

189. Provention Bio Inc.

-190.05%

196. UroGen Pharma Ltd.

-203.14%

197. Histogen Inc.

-204.40%

199. Moleculin Biotech Inc.

-209.13%

202. OTONOMY INC.

-217.89%

203. Aptinyx Inc.

-217.91%

205. ABVC BIOPHARMA INC.

-221.72%

207. MANNKIND CORP

-222.40%

208. TREVENA INC

-223.26%

213. Pulmatrix Inc.

-233.74%

214. iBio Inc.

-234.16%

219. Clovis Oncology Inc.

-240.23%

220. Savara Inc

-241.30%

223. BeiGene Ltd.

-249.18%

225. Aadi Bioscience Inc.

-250.54%

226. CEN BIOTECH INC

-254.43%

229. OMEROS CORP

-263.32%

230. MyoKardia Inc.

-266.16%

232. OptiNose Inc.

-267.21%

233. TherapeuticsMD Inc.

-269.73%

236. MUSTANG BIO INC.

-276.20%

237. NANOVIRICIDES INC.

-276.66%

239. Lipocine Inc.

-277.89%

241. Sage Therapeutics Inc.

-280.96%

245. PROTEO INC

-288.15%

247. Ocuphire Pharma Inc.

-301.71%

248. Rebus Holdings Inc.

-305.33%

254. AYTU BIOPHARMA INC

-328.31%

256. ROCKWELL MEDICAL INC.

-340.29%

261. Sesen Bio Inc.

-364.73%

262. MusclePharm Corp

-377.30%

263. KEMPHARM INC

-380.14%

266. CTI BIOPHARMA CORP

-389.94%

268. SCYNEXIS INC

-402.08%

276. Verastem Inc.

-422.83%

277. Zosano Pharma Corp

-431.46%

281. OCULAR THERAPEUTIX INC

-440.28%

288. TG THERAPEUTICS INC.

-458.84%

289. PLx Pharma Inc.

-460.06%

290. Neurotrope Inc.

-460.21%

291. Evelo Biosciences Inc.

-461.62%

293. CohBar Inc.

-465.05%

297. ZOGENIX INC.

-491.17%

299. VYNE Therapeutics Inc.

-497.90%

300. BIOVIE INC.

-502.33%

301. CARDAX INC.

-508.98%

302. Jaguar Health Inc.

-512.30%

303. SOLIGENIX INC.

-517.47%

304. CHIMERIX INC

-521.51%

309. ONCOSEC MEDICAL Inc

-539.86%

312. CANNAPHARMARX INC.

-569.61%

313. Evoke Pharma Inc

-573.35%

315. Urovant Sciences Ltd.

-588.64%

318. NANOMIX Corp

-624.70%

321. Statera Biopharma Inc.

-679.58%

325. vTv Therapeutics Inc.

-721.85%

326. HUMANIGEN INC

-749.07%

327. Acer Therapeutics Inc.

-808.04%

328. EYENOVIA INC.

-826.77%

332. GeoVax Labs Inc.

-904.09%

335. CytoDyn Inc.

-939.25%

337. Ainos Inc.

-976.70%

340. Rezolute Inc.

-1069.65%

342. Anixa Biosciences Inc

-1098.14%

343. Adhera Therapeutics Inc.

-1109.47%

344. Iterum Therapeutics plc

-1151.45%

345. Intec Pharma Ltd.

-1163.99%

346. Propanc Biopharma Inc.

-1184.18%

348. BIOXYTRAN INC

-1360.41%

349. Wellness Center USA Inc.

-1457.60%

350. Q BioMed Inc.

-1494.97%

351. Evofem Biosciences Inc.

-1502.83%

352. LEAP THERAPEUTICS INC.

-1633.60%

353. Hoth Therapeutics Inc.

-1748.66%

355. Earth Science Tech Inc.

-1792.69%

356. SEELOS THERAPEUTICS INC.

-1874.89%

357. Genprex Inc.

-1974.45%

358. VACCINEX INC.

-2296.90%

359. CANNAPOWDER INC.

-2431.64%

360. One World Products Inc.

-2829.46%

361. ProtoKinetix Inc.

-5373.34%

362. NEXIEN BIOPHARMA INC.

-9661.36%

United States Ratings

German Insurance Ratings